Global Data Hub - Health data
par plusieurs auteurs
Helen Farr discusses the use of the NHS COVID-19 App at work for life sciences businesses with European Pharmaceutical Review
par Helen Farr
Targeted treatments – Part 4: patenting digital devices
Important advances are being driven by digital communications technology, particularly in the medical devices sector.
par Dr Paul England
5 de 6 Publications
Goodbye CE, hello UKCA
par Katie Chandler et Justyna Ostrowska
Alison Dennis discusses the new framework for regulating medical devices and IVDs
par Alison Dennis
Justyna Ostrowska discusses the impact of new MHRA Apps Guidance on the digital health industry
Brexit readiness for overseas medical devices manufacturers: trade marks
par plusieurs auteurs
Return to work: key issues for life sciences
par Helen Farr et Adrian Toutoungi
Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
par plusieurs auteurs
4 de 6 Publications
Conférences et Webinars
Retrouvez les analyses de nos experts sur les dernières questions juridiques.
Voir tous les évènementsGlobal Data Hub - Health data
par plusieurs auteurs
Helen Farr discusses the use of the NHS COVID-19 App at work for life sciences businesses with European Pharmaceutical Review
par Helen Farr
Targeted treatments – Part 4: patenting digital devices
Important advances are being driven by digital communications technology, particularly in the medical devices sector.
par Dr Paul England
5 de 6 Publications
Goodbye CE, hello UKCA
par Katie Chandler et Justyna Ostrowska
Alison Dennis discusses the new framework for regulating medical devices and IVDs
par Alison Dennis
Justyna Ostrowska discusses the impact of new MHRA Apps Guidance on the digital health industry
Brexit readiness for overseas medical devices manufacturers: trade marks
par plusieurs auteurs
Return to work: key issues for life sciences
par Helen Farr et Adrian Toutoungi
Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
par plusieurs auteurs
4 de 6 Publications